HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$20.06
Day range
$19.69 - $20.10
Year range
$9.26 - $26.70
Market cap
547.88M USD
Avg Volume
177.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 66.12M | 72.47% |
Operating expense | 59.36M | 14.25% |
Net income | -2.58M | 87.49% |
Net profit margin | -3.90 | 92.75% |
Earnings per share | -0.10 | 87.18% |
EBITDA | -2.43M | 88.00% |
Effective tax rate | -1.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 243.10M | -6.00% |
Total assets | 453.34M | 1.34% |
Total liabilities | 62.07M | 28.83% |
Total equity | 391.27M | — |
Shares outstanding | 27.45M | — |
Price to book | 1.41 | — |
Return on assets | -3.18% | — |
Return on capital | -3.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -2.58M | 87.49% |
Cash from operations | 18.59M | 409.78% |
Cash from investing | -7.67M | -71.17% |
Cash from financing | -3.30M | -339.60% |
Net change in cash | 7.62M | 167.82% |
Free cash flow | 16.25M | 19,722.56% |
About
Founded
2007
Headquarters
Website
Employees
610
